Health Care and Profits, a Poor Mix / NY Times
An excellent piece discusses how turning over aspects of healthcare to private industry led to greater costs without accompanying benefits, and compares the US with other first world countries.
An excellent piece discusses how turning over aspects of healthcare to private industry led to greater costs without accompanying benefits, and compares the US with other first world countries.
Susannah Cahalan’s NY Post story provides a needed counterpoint to last week’s Washington Post puff piece on the Bruce Ivins case. Who would have expected to find higher journalistic standards at the NY Post than at its Washington namesake? New information in this story includes the fact that the FBI was renting the house next…
But FBI’s report, documents and accompanying information (only pertaining to Ivins, not to the rest of the investigation) were released on Friday afternoon… which means the FBI anticipated doubt and ridicule. And the National Academies of Science (NAS) is several months away from issuing its $879,550 report on the microbial forensics, suggesting a) asking NAS…
It might not be murder, but there was definite hanky panky at the scene of David Kelly’s death. Not only did the knife, the water bottle and the pill package on Dr. Kelly’s person lack any fingerprints. Turns out his cell phone and a watch had also been wiped clean. Since there were no gloves…
https://live.childrenshealthdefense.org/chd-tv/shows/good-morning-chd/attempted-world-takeover-with-james-corbett–james-roguski/
Utter garbage on quarantines from the WHO. Trust the science. https://www.reuters.com/business/healthcare-pharmaceuticals/who-sees-more-evidence-that-omicron-affects-upper-respiratory-tract-2022-01-04/ “As case numbers due to Omicron have soared, some countries, including the United States, have cut down isolation or quarantine periods in a bid to allow asymptomatic people to return to work or school. Mahamud [WHO Incident Manager Abdi Mahamud] said that leaders should decide based…
From the Aug 1, 2009 Lancet online: Last week, Australia and the USA announced that they would begin trials of an H1N1 vaccine. Vaccination against H1N1 will be an important development in controlling the impact of the pandemic. However, several thorny issues exist around vaccine manufacture and approval. All countries will require the vaccine but…